Abeona Therapeutics Inc.
ABEO
$4.40
-$0.20-4.35%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -36.51% | 43.58% | 50.77% | 70.59% | 53.26% |
| Total Depreciation and Amortization | -30.13% | -26.83% | -19.80% | -3.12% | 2.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 737.90% | -82.48% | -96.82% | -131.43% | -107.48% |
| Change in Net Operating Assets | 69.65% | 67.67% | 58.92% | 63.86% | 67.74% |
| Cash from Operations | 14.89% | 30.10% | 32.36% | 36.84% | 33.78% |
| Capital Expenditure | -154.62% | 90.49% | 92.62% | 93.57% | 96.87% |
| Sale of Property, Plant, and Equipment | -88.24% | -79.18% | -71.35% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.31% | -430.29% | -144.59% | -139.49% | -136.41% |
| Cash from Investing | 100.87% | -492.61% | -147.09% | -139.52% | -136.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -20.38% | 267.59% | 241.88% | 158.70% | 95.42% |
| Repurchase of Common Stock | -3,540.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | 100.00% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -101.56% | -101.08% | -100.48% | -- |
| Cash from Financing | -14.17% | 332.29% | 321.07% | 127.41% | 73.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.05% | 82.13% | 66.14% | -293.12% | -196.10% |
